Structures by: Yathirajan H. S.
Total: 746
Flunarizinium succinate
C26H27F2N2,C4H5O4
Acta Crystallographica Section E (2013) 69, 2 o260-o261
a=10.7824(2)Å b=10.6270(2)Å c=11.2364(2)Å
α=90.00° β=91.6780(10)° γ=90.00°
Orphenadrinium dihydrogen citrate
C18H24NO,C6H7O7
Acta Crystallographica Section E (2013) 69, 2 o248
a=9.9515(8)Å b=10.7382(9)Å c=12.6250(10)Å
α=98.863(7)° β=104.391(7)° γ=111.498(8)°
2-(3,4-Dichlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro- 1<i>H</i>-pyrazol-4-yl)acetamide
C19H17Cl2N3O2
Acta Crystallographica Section E (2013) 69, 3 o402-o403
a=17.2064(8)Å b=20.7984(9)Å c=15.6102(7)Å
α=90.00° β=101.213(4)° γ=90.00°
Ethyl 6-(6-methoxynaphthalen-2-yl)-4-(naphthalen-2-yl)-2-oxocyclohex-3-ene-1-carboxylate
C30H26O4
Acta Crystallographica Section E (2013) 69, 3 o352
a=18.4688(10)Å b=11.2940(6)Å c=10.9676(5)Å
α=90.00° β=96.082(5)° γ=90.00°
(<i>E</i>)-<i>N</i>'-(4-Fluorobenzylidene)-2-(3-methylphenyl)acetohydrazide
C16H15FN2O
Acta Crystallographica Section E (2013) 69, 3 o421
a=11.8535(7)Å b=12.3769(9)Å c=20.8721(11)Å
α=98.549(5)° β=103.074(5)° γ=105.134(6)°
<i>N</i>-(4-Bromophenyl)acetamide
C8H8BrNO
Acta Crystallographica Section E (2013) 69, 3 o461
a=6.7250(7)Å b=9.3876(11)Å c=14.4434(14)Å
α=90.00° β=117.750(4)° γ=90.00°
2-(2,6-Dichlorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H8Cl2N2OS
Acta Crystallographica Section E (2013) 69, 4 o523
a=7.1278(4)Å b=8.4434(4)Å c=10.3637(6)Å
α=95.341(4)° β=106.140(5)° γ=96.745(4)°
(<i>Z</i>)-4-[2-(2,4-Dimethylphenyl)hydrazinylidene]-3-methylpyrazol-5(1<i>H</i>)-one
C12H14N4O
Acta Crystallographica Section E (2013) 69, 4 o532
a=5.2926(2)Å b=22.1675(6)Å c=10.0529(3)Å
α=90.00° β=101.770(3)° γ=90.00°
4-Amino-<i>N</i>-<i>tert</i>-butyl-5-oxo-3-(propan-2-yl)-1<i>H</i>-1,2,4-triazole-1-carboxamide
C10H19N5O2
Acta Crystallographica Section E (2013) 69, 4 o603
a=11.0298(2)Å b=12.2135(4)Å c=14.8542(4)Å
α=92.244(2)° β=95.7020(19)° γ=93.379(2)°
Cinnarizinium bis(<i>p</i>-toluenesulfonate) dihydrate
C26H30N22,2(C7H7O3S),2(H2O)
Acta Crystallographica Section E (2013) 69, 4 o485-o486
a=10.0845(2)Å b=14.6026(3)Å c=25.8591(6)Å
α=90.00° β=93.414(2)° γ=90.00°
(4-Methylpiperazin-1-yl)-(2,3,4-trimethoxybenzylidene)amine
C15H23N3O3
Acta Crystallographica Section E (2014) 70, 4 o500
a=7.84207(14)Å b=14.2305(3)Å c=27.6218(5)Å
α=90° β=90° γ=90°
6-Chloro-2-chloromethyl-4-phenylquinazoline 3-oxide
C15H10Cl2N2O
Acta Crystallographica Section E (2014) 70, 4 o440-o441
a=8.2030(3)Å b=14.3203(5)Å c=11.8477(4)Å
α=90° β=105.016(4)° γ=90°
{2-[(1<i>H</i>-Indol-3-ylmethylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl}(phenyl)methanone
C24H20N2OS
Acta Crystallographica Section E (2014) 70, 4 o501-o502
a=8.66858(16)Å b=21.8200(4)Å c=10.41956(18)Å
α=90° β=108.1709(19)° γ=90°
{2-[(2-Hydroxy-benzylidene)-amino]-4,5,6,7-tetrahydro-benzo[b]thiophen-3-yl}- phenyl-methanone
C22H19NO2S
Acta Crystallographica Section E (2014) 70, 4 o476-o477
a=9.26395(15)Å b=14.2886(2)Å c=13.6476(2)Å
α=90° β=96.7581(15)° γ=90°
5-(4-fluoro-phenyl)-2H-pyrazol-1-ium trifluoro-acetate
C9H8FN2,C2F3O2
Acta Crystallographica Section E (2014) 70, 4 o429-o430
a=6.7828(2)Å b=16.8263(6)Å c=10.4004(4)Å
α=90° β=93.354(3)° γ=90°
[2-(Benzylideneamino)-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl](phenyl)methanone
C22H19NOS
Acta Crystallographica Section E (2014) 70, 5 o507-o508
a=8.78760(16)Å b=14.0091(3)Å c=14.4120(2)Å
α=90° β=94.8913(17)° γ=90°
{2-[(2-Bromo-5-methoxybenzylidene)amino]-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophen-3-yl}(phenyl)methanone
C23H20BrNO2S
Acta Crystallographica Section E (2014) 70, 5 o581-o582
a=8.84813(17)Å b=12.5563(2)Å c=18.4384(4)Å
α=90° β=102.363(2)° γ=90°
1-3-aminopropyl imidazolium 3,5- dinitrosalicylate
C6H12N3,C7H3N2O7
Acta Crystallographica Section E (2014) 70, 3 o318-o319
a=7.0109(4)Å b=10.6617(8)Å c=10.7454(7)Å
α=93.075(6)° β=95.863(5)° γ=104.944(6)°
1-Piperonylpiperazinium p-chlorobenzoate
C12H17N2O2,C7H4ClO2
Acta Crystallographica Section E (2014) 70, 3 o283-o284
a=16.9967(6)Å b=8.5990(3)Å c=12.4150(5)Å
α=90° β=90.923(3)° γ=90°
1-(3,4-Dimethoxyphenyl)-3-phenylprop-2-en-1-one
C17H16O3
Acta Crystallographica Section E (2014) 70, 3 o368
a=7.3269(7)Å b=9.8923(11)Å c=10.7668(11)Å
α=102.408(9)° β=109.255(9)° γ=98.951(9)°
2-{(4-Chlorophenyl)[2-(dimethylazaniumyl)ethoxy]methyl}pyridinium bis(2,4,6-trinitrophenolate)
C16H21ClN2O2,2(C6H2N3O7)
Acta Crystallographica Section E (2013) 69, 8 o1264-o1265
a=8.1719(6)Å b=8.5341(6)Å c=23.5868(16)Å
α=83.771(6)° β=85.484(6)° γ=74.827(6)°
Flunarizinium hydrogen maleate
C26H27F2N2,C4H3O4
Acta Crystallographica Section E (2013) 69, 8 o1344
a=22.1215(5)Å b=10.8620(2)Å c=11.3215(2)Å
α=90° β=98.879(2)° γ=90°
2-(3,4-Dichlorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H8Cl2N2OS
Acta Crystallographica Section E (2013) 69, 5 o645-o646
a=4.6185(3)Å b=7.7741(7)Å c=17.1188(12)Å
α=100.278(7)° β=94.250(6)° γ=105.001(7)°
2-(4-Chlorophenyl)-<i>N</i>-(3,4-difluorophenyl)acetamide
C14H10ClF2NO
Acta Crystallographica Section E (2013) 69, 6 o996-o997
a=4.8935(5)Å b=5.8995(6)Å c=42.572(4)Å
α=90° β=90° γ=90°
(2<i>E</i>)-1-(4-Chlorophenyl)-3-(4-nitrophenyl)prop-2-en-1-one
C15H10ClNO3
Acta Crystallographica Section E (2013) 69, 5 o790-o791
a=42.9266(17)Å b=5.9741(3)Å c=5.0680(2)Å
α=90° β=90° γ=90°
2-(2,4-Dichlorophenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C11H8Cl2N2OS
Acta Crystallographica Section E (2013) 69, 5 o656-o657
a=5.3262(2)Å b=10.5083(4)Å c=10.8096(4)Å
α=83.900(3)° β=86.301(3)° γ=87.279(4)°
4-Hydroxy-<i>N</i>-methylbenzamide
C8H9NO2
Acta Crystallographica Section E (2013) 69, 5 o738
a=13.576(3)Å b=16.964(3)Å c=11.025(2)Å
α=90° β=120.11(3)° γ=90°
2-(4-Bromophenyl)-<i>N</i>-(3,4-difluorophenyl)acetamide
C14H10BrF2NO
Acta Crystallographica Section E (2013) 69, 6 o900-o901
a=4.9136(3)Å b=6.0218(4)Å c=42.514(2)Å
α=90° β=90° γ=90°
Rupatidine
C26H26ClN3
Acta Crystallographica Section E (2013) 69, 6 o980
a=10.2655(3)Å b=11.3341(4)Å c=18.8111(6)Å
α=90° β=90.874(3)° γ=90°
Methyl 2-{2-[(2-methylphenoxy)methyl]phenyl}-2-oxoacetate
C17H16O4
Acta Crystallographica Section E (2013) 69, 5 o671
a=31.6697(11)Å b=7.5883(2)Å c=12.5915(6)Å
α=90° β=108.514(4)° γ=90°
2-[(2-Chlorophenyl)(hydroxy)methyl]phenol
C13H11ClO2
Acta Crystallographica Section E (2013) 69, 8 o1240
a=23.4627(8)Å b=23.4627(8)Å c=11.3722(4)Å
α=90° β=90° γ=120°
Methyl 2-[4-(trifluoromethyl)phenylsulfanyl]benzoate
C15H11F3O2S
Acta Crystallographica Section E (2013) 69, 11 o1670
a=11.0675(5)Å b=8.0429(3)Å c=15.6614(7)Å
α=90° β=96.654(5)° γ=90°
4-Methyl-<i>N</i>-(4-nitrobenzylidene)piperazin-1-amine
C12H16N4O2
Acta Crystallographica Section E (2013) 69, 11 o1687-o1688
a=27.9353(14)Å b=5.9247(3)Å c=18.7763(7)Å
α=90° β=126.527(3)° γ=90°
4-(3-Fluoro-4-methylanilino)-2-methylidene-4-oxobutanoic acid
C12H12FNO3
Acta Crystallographica Section E (2013) 69, 12 o1752
a=6.3368(3)Å b=8.2642(4)Å c=21.0277(11)Å
α=84.057(4)° β=89.798(4)° γ=86.062(4)°
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)- 2-phenylacetamide
C19H19N3O2
Acta Crystallographica Section E (2013) 69, 12 o1726-o1727
a=10.1258(7)Å b=10.4671(8)Å c=17.8888(12)Å
α=100.833(6)° β=92.527(5)° γ=116.812(7)°
Ethyl 6-(4-chlorophenyl)-4-(4-fluorophenyl)-2-oxocyclohex-3-ene-1-carboxylate
C21H18ClFO3
Acta Crystallographica Section E (2013) 69, 12 o1839-o1840
a=11.6611(5)Å b=13.1823(5)Å c=13.2251(5)Å
α=77.250(3)° β=87.320(3)° γ=67.342(4)°
1-Piperonylpiperazinium 4-nitrobenzoate monohydrate
C12H17N2O2,C7H4NO4,H2O
Acta Crystallographica Section E (2014) 70, 3 o270-o271
a=6.0745(5)Å b=12.0617(11)Å c=13.4817(10)Å
α=92.561(7)° β=98.753(7)° γ=93.326(7)°
<i>N</i>-[3-(2-Chlorobenzoyl)-5-ethylthiophen-2-yl]-2-[(<i>E</i>)-(2-hydroxybenzylidene)amino]acetamide
C22H19ClN2O3S
Acta Crystallographica Section E (2014) 70, 9 o1011-o1012
a=9.7888(2)Å b=16.9476(3)Å c=12.2863(3)Å
α=90° β=90.6654(19)° γ=90°
3-[4-(Pyrimidin-2-yl)piperazin-1-ium-1-yl]butanoate
C12H18N4O2
Acta Crystallographica Section E (2014) 70, 9 o1063-o1064
a=13.5157(6)Å b=7.8454(3)Å c=12.2147(5)Å
α=90° β=106.884(5)° γ=90°
4-(Pyrimidin-2-yl)piperazin-1-ium chloride
C8H13N4,Cl
Acta Crystallographica Section E (2014) 70, 10 203-206
a=6.84764(17)Å b=7.27667(18)Å c=19.1751(5)Å
α=90° β=90° γ=90°
4-(Pyrimidin-2-yl)piperazin-1-ium nitrate
C8H13N4,NO3
Acta Crystallographica Section E (2014) 70, 10 203-206
a=10.5272(6)Å b=7.2230(3)Å c=14.1575(7)Å
α=90° β=107.341(6)° γ=90°
Methyl (1<i>RS</i>, 6<i>SR</i>)-4-(4-chlorophenyl)-6-[4-(propan-2-yl)phenyl]-2-oxocyclohex-3-ene-1-carboxylate
C23H23ClO3
Acta Crystallographica Section C (2015) 71, 7
a=17.4871(11)Å b=11.5900(8)Å c=10.0167(7)Å
α=90° β=95.300(2)° γ=90°
2-(2-Chlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)acetamide
C19H18ClN3O2
Acta Crystallographica Section C (2016) 72, 9
a=23.023(3)Å b=8.2976(10)Å c=21.602(3)Å
α=90° β=120.957(14)° γ=90°
1-(4-Methoxyphenyl)-1<i>H</i>-pyrazole-3,4-dicarbohydrazide
C12H14N6O3
Acta Crystallographica Section E (2018) 74, 12 1783-1789
a=7.6030(6)Å b=22.6605(19)Å c=7.6751(7)Å
α=90° β=102.284(3)° γ=90°
Bis(2-amino-4,4,7,7-tetramethyl-4,5,6,7-tetrahydro-1,3-benzothiazol-3-ium) succinate--2-amino-4,4,7,7-tetramethyl-4,5,6,7-tetrahydro-1,3-benzothiazol-3-ium hydrogen succinate 4,4,7,7-tetramethyl-3a,5,6,7a-tetrahydrobenzothiazol-2-ylamine (1/1)
1.5(C11H19N2S),0.5(C4H4O42),0.5(C4H5O4),0.5(C11H18N2S)
Acta crystallographica. Section E, Crystallographic communications (2019) 75, Pt 2 167-174
a=8.9437(3)Å b=14.7253(4)Å c=11.2676(4)Å
α=90° β=100.493(3)° γ=90°
3,5-Bis(4-fluorophenyl)-1-phenyl-1<i>H</i>-pyrazole
C21H14F2N2
Acta Crystallographica Section C (2014) 70, 9
a=31.729(2)Å b=10.4118(7)Å c=10.1697(6)Å
α=90° β=97.700(7)° γ=90°